| Integrating oncolytic viruses in combination cancer immunotherapy PK Bommareddy, M Shettigar, HL Kaufman Nature Reviews Immunology 18 (8), 498-513, 2018 | 555 | 2018 |
| Talimogene laherparepvec (T-VEC) and other oncolytic viruses for the treatment of melanoma PK Bommareddy, A Patel, S Hossain, HL Kaufman American journal of clinical dermatology 18 (1), 1-15, 2017 | 254 | 2017 |
| Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer JH Newman, CB Chesson, NL Herzog, PK Bommareddy, SM Aspromonte, ... Proceedings of the National Academy of Sciences 117 (2), 1119-1128, 2020 | 154 | 2020 |
| Oncolytic viruses—natural and genetically engineered cancer immunotherapies SR Jhawar, A Thandoni, PK Bommareddy, S Hassan, FJ Kohlhapp, ... Frontiers in Oncology 7, 202, 2017 | 145 | 2017 |
| Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1 S Thomas, L Kuncheria, V Roulstone, JN Kyula, D Mansfield, ... Journal for immunotherapy of cancer 7, 1-17, 2019 | 114 | 2019 |
| MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation PK Bommareddy, S Aspromonte, A Zloza, SD Rabkin, HL Kaufman Science translational medicine 10 (471), eaau0417, 2018 | 114 | 2018 |
| Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma PK Bommareddy, A Zloza, SD Rabkin, HL Kaufman Oncoimmunology 8 (7), e1591875, 2019 | 100 | 2019 |
| Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop D Bedognetti, M Ceccarelli, L Galluzzi, R Lu, K Palucka, J Samayoa, ... Journal for immunotherapy of cancer 7, 1-23, 2019 | 78 | 2019 |
| Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response L Poillet-Perez, DW Sharp, Y Yang, SV Laddha, M Ibrahim, ... Nature cancer 1 (9), 923-934, 2020 | 68 | 2020 |
| Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration MN Stein, J Malhotra, RS Tarapore, U Malhotra, AW Silk, N Chan, ... Journal for immunotherapy of cancer 7, 1-9, 2019 | 57 | 2019 |
| Intratumoral approaches for the treatment of melanoma PK Bommareddy, AW Silk, HL Kaufman The Cancer Journal 23 (1), 40-47, 2017 | 54 | 2017 |
| Oncolytic herpes simplex virus encoding IL12 controls triple-negative breast cancer growth and metastasis SM Ghouse, HM Nguyen, PK Bommareddy, K Guz-Montgomery, D Saha Frontiers in oncology 10, 384, 2020 | 51 | 2020 |
| Clinical responses of oncolytic coxsackievirus A21 (V937) in patients with unresectable melanoma RHI Andtbacka, B Curti, GA Daniels, S Hallmeyer, ED Whitman, J Lutzky, ... Journal of Clinical Oncology 39 (34), 3829-3838, 2021 | 50 | 2021 |
| Sensory-derived glutamate regulates presynaptic inhibitory terminals in mouse spinal cord M Mende, EV Fletcher, JL Belluardo, JP Pierce, PK Bommareddy, ... Neuron 90 (6), 1189-1202, 2016 | 46 | 2016 |
| Abstract CT026: Phase 1b study of intratumoral Coxsackievirus A21 (CVA21) and systemic pembrolizumab in advanced melanoma patients: Interim … AW Silk, H Kaufman, N Gabrail, J Mehnert, J Bryan, J Norrell, D Medina, ... Cancer Research 77 (13_Supplement), CT026-CT026, 2017 | 45 | 2017 |
| Oncolytic herpes simplex viruses as a paradigm for the treatment of cancer PK Bommareddy, C Peters, D Saha, SD Rabkin, HL Kaufman Annual Review of Cancer Biology 2, 155-173, 2018 | 36 | 2018 |
| Two roads for oncolytic immunotherapy development HL Kaufman, PK Bommareddy Journal for immunotherapy of cancer 7 (1), 26, 2019 | 35 | 2019 |
| A role for dystonia-associated genes in spinal GABAergic interneuron circuitry J Zhang, JAP Weinrich, JB Russ, JD Comer, PK Bommareddy, ... Cell reports 21 (3), 666-678, 2017 | 28 | 2017 |
| Non-oncogenic acute viral infections disrupt anti-cancer responses and lead to accelerated cancer-specific host death FJ Kohlhapp, EJ Huelsmann, AT Lacek, JM Schenkel, J Lusciks, ... Cell reports 17 (4), 957-965, 2016 | 27 | 2016 |
| Unleashing the therapeutic potential of oncolytic viruses PK Bommareddy, HL Kaufman The Journal of clinical investigation 128 (4), 1258-1260, 2018 | 25 | 2018 |
Jenna NewmanPostdoctoral Fellow at Icahn School of Medicine at Mount SinaiVerified email at mssm.edu
